| Dr Arjun Venkataramani, MD | |
|
570 White Pond Dr, Suite 100, Akron, OH 44320-4205 | |
| (330) 869-0124 | |
| (330) 869-2852 |
| Full Name | Dr Arjun Venkataramani |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 35 Years |
| Location | 570 White Pond Dr, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952392938 | NPI | - | NPPES |
| 341296621 | Other | OH | CHAMPUS |
| 2110450 | Medicaid | OH | |
| 8466976 | Other | OH | AETNA |
| 101785 | Other | OH | KAISER |
| 2900591 | Other | OH | UHC |
| 34129662100 | Other | OH | CAREWORKS |
| 341296621030 | Other | OH | CARESOURCE |
| 730008 | Other | OH | BUCKEYE MEDICAID |
| 000000129697 | Other | OH | BCBS |
| 100014409 | Other | OH | RAILROAD MEDICARE |
| 341296621V | Other | OH | SUMMACARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 35075769V (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wyandot Memorial Hospital | Upper sandusky, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wyandot Memorial Hospital | 1557340189 | 65 |
News Archive
A Washington Post editorial examines the future of PEPFAR under the Obama administration, as outlined in a five-year strategy released earlier this month. Though "[m]any organizations, including Doctors Without Borders, continue to worry that Mr. Obama is 'flat-lining' funding for the vital program," this "ignores Mr. Obama's move to make PEPFAR the center of a larger $63 billion global health initiative to develop more comprehensive and integrated approaches to care," the editorial writes.
The Senate is expected to approve on Friday a continuing resolution that provides funding to keep the federal government operating but strips out language passed by the House that would defund the health law. This move will set up heightened conflict with the House, where some conservative Republicans are standing firm in their pledge to oppose any measure that does not further their goal of dismantling Obamacare. In the background, the countdown to a government shutdown continues.
Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on Sept. 22, 2014.
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.
› Verified 1 days ago
| Entity Name | Wyandot Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477554475 PECOS PAC ID: 1557340189 Enrollment ID: O20040716001163 |
News Archive
A Washington Post editorial examines the future of PEPFAR under the Obama administration, as outlined in a five-year strategy released earlier this month. Though "[m]any organizations, including Doctors Without Borders, continue to worry that Mr. Obama is 'flat-lining' funding for the vital program," this "ignores Mr. Obama's move to make PEPFAR the center of a larger $63 billion global health initiative to develop more comprehensive and integrated approaches to care," the editorial writes.
The Senate is expected to approve on Friday a continuing resolution that provides funding to keep the federal government operating but strips out language passed by the House that would defund the health law. This move will set up heightened conflict with the House, where some conservative Republicans are standing firm in their pledge to oppose any measure that does not further their goal of dismantling Obamacare. In the background, the countdown to a government shutdown continues.
Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on Sept. 22, 2014.
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arjun Venkataramani, MD 570 White Pond Dr, Suite 100, Akron, OH 44320-4205 Ph: (330) 869-0124 | Dr Arjun Venkataramani, MD 570 White Pond Dr, Suite 100, Akron, OH 44320-4205 Ph: (330) 869-0124 |
News Archive
A Washington Post editorial examines the future of PEPFAR under the Obama administration, as outlined in a five-year strategy released earlier this month. Though "[m]any organizations, including Doctors Without Borders, continue to worry that Mr. Obama is 'flat-lining' funding for the vital program," this "ignores Mr. Obama's move to make PEPFAR the center of a larger $63 billion global health initiative to develop more comprehensive and integrated approaches to care," the editorial writes.
The Senate is expected to approve on Friday a continuing resolution that provides funding to keep the federal government operating but strips out language passed by the House that would defund the health law. This move will set up heightened conflict with the House, where some conservative Republicans are standing firm in their pledge to oppose any measure that does not further their goal of dismantling Obamacare. In the background, the countdown to a government shutdown continues.
Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 28 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on Sept. 22, 2014.
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, and SpringWorks Therapeutics, a clinical-stage rare disease and oncology company focused on sourcing and developing innovative treatments for underserved patient populations, announced today that the companies have entered into a global clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining BeiGene's investigational RAF dimer inhibitor, lifirafenib and SpringWorks Therapeutics' investigational MEK inhibitor, PD-0325901, in patients with advanced solid tumors.
› Verified 1 days ago
Dr. Michael A Pelini, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St, Ste 300, Akron, OH 44304 Phone: 330-376-7000 Fax: 330-376-1066 | |
David P. Lang, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 4125 Medina Rd, #200c, Akron, OH 44333 Phone: 330-665-8031 Fax: 330-665-8360 | |
Ms. Tiffany Mccann, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3561 | |
Jonathan Buggey, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 95 Arch St Ste 300, Akron, OH 44304 Phone: 724-422-6808 | |
Shamsa Baaj, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000 | |
Mira Rohit Patel, DO Gastroenterology Medicare: Medicare Enrolled Practice Location: 161 N Forge St Ste 198, Akron, OH 44304 Phone: 330-375-3039 | |
Richard J Streck, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, 5th Floor Ambulatory Care Center, Akron, OH 44307 Phone: 330-344-6015 Fax: 330-344-6820 |